Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.3751
-0.0379 (-9.18%)
At close: Sep 12, 2025, 4:00 PM EDT
0.3611
-0.0140 (-3.73%)
After-hours: Sep 12, 2025, 7:44 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $58.52 million as of September 12, 2025. Its market cap has decreased by -78.21% in one year.
Market Cap
58.52M
Enterprise Value
111.26M
1-Year Change
-78.21%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $58.52M, a decrease of -82.60%. That is a compound annual growth rate of -30.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 58.52M | -73.71% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
| Oct 28, 2020 | 336.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |